Clinical Trial Update: Linsitinib in Treating Patients With Gastrointestinal Stromal Tumors [Phase 2]

View source ↗

Summary

Phase 2 trial of linsitinib in patients with gastrointestinal stromal tumors (and related conditions) has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Carney Complex
• Chondrosarcoma
• Gastrointestinal Stromal Tumor
• Paraganglioma

Drugs mentioned

• Linsitinib (linsitinib)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Carney Complex, Chondrosarcoma | Phase 2 | Status: COMPLETED | Results posted: 2017-01-19